Senussi’s Tribe to Asharq Al-Awsat: We Don’t Know if He’s Dead or Alive

Abdullah al-Senussi seen in court. (Reuters file photo)
Abdullah al-Senussi seen in court. (Reuters file photo)
TT

Senussi’s Tribe to Asharq Al-Awsat: We Don’t Know if He’s Dead or Alive

Abdullah al-Senussi seen in court. (Reuters file photo)
Abdullah al-Senussi seen in court. (Reuters file photo)

Libya’s Magarha tribe stressed that it does not know the fate of its son, Abdullah al-Senussi, former chief of intelligence in the regime of ousted ruler Moammar al-Gaddafi.

Senior member of the tribe, Sheikh Haroun Arhouma told Asharq Al-Awsat: “We will not remain silent if something were to happen to him.”

Senussi, also Gaddafi’s son-in-law, was one of the top officials in the former regime. He was sentenced to death in 2015 for suppressing the February 17, 2011, revolution protests. At 72, he is suffering from cancer, and according to his tribe, is being denied treatment and medical care.

Sheikh Haroun said Senussi’s health is “very poor”, revealing that he is suffering from heart problems, as well as liver cancer.

Several parties have held the authorities responsible for his ongoing imprisonment even though former regime figures have been released from jail.

Sheikh Haroun also held the United Nations mission accountable for his safety.

“We have not seen him since Ramadan,” said Sheikh Haround, adding that his three children have been prevented from visiting him.

“We don’t know whether he is dead or alive,” he added.

Senussi is being held in Mitiga prison in the capital Tripoli. The facility is controlled by the Special Deterrence Force militia, headed by Abdel Raouf Kara.

Sheikh Haroun said the tribe was informed that Senussi had undergone heart surgery two months ago, but his relatives have yet to see him.

On assertions by Senussi’s daughter that he is in poor health, Sheikh Haroun declared: “I hold the UN, the Government of National Unity (GNU), headed by Abdulhamid al-Dbeibah, and the Presidential Council responsible for his safety.

He revealed that the tribe had twice met with Dbeibah, head of the Council, Mohammed al-Menfi, and High Council of State chief Khalid al-Mishri to seek Senussi’s release but to no avail.

The UN Support Mission in Libya “has done nothing even though we have pleaded with it dozens of times to act,” revealed Sheikh Haroun.

The mission has long called for the release of people who have been “arbitrarily” detained, but it also says that it refuses to become embroiled in the judiciary and respects its rulings.

Senussi was part of Gaddafi’s inner circle. He was close to the deposed leader for 42 years and is wanted by the International Criminal Court.

His supporters say he is being targeted because he was and still is an influential figure in Libya, while his opponents say he played a primary role in quelling the revolt.

Sheikh Haroun speculated that Senussi is being kept in prison because “he is loved by all regions in Libya.”

“The majority of the people want him to be released,” he added, suggesting that international powers, such as Britain and the United States, have been pressuring the Deterrence Force against releasing him.

“Had it not been for Senussi, the former regime would have collapsed a long time ago,” continued Sheikh Haroun.

“If he were to be released, then he would be able to activate the national reconciliation due to his good ties with all parties, including the armed forces and brother Khalifa Haftar [commander of the Libyan National Army],” he remarked.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.